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Lipid transfer protein (LTP) is a major allergen in peach
often causing anaphylactic reactions with a high preva-
lence of sensitization in the Mediterranean area. The
prevalence of LTP sensitization in Central Europe is
currently unknown, where the diagnosis is complicated
by a high background sensitization to the major birch
pollen allergen, Bet v 1, and Bet v 1 cross-reactive food
allergens, which cause only mild reactions. LTP and Bet
v 1-related proteins are both distributed throughout the
plant-kingdom. In this study, we aimed to characterize
the sensitization-patterns of patients with severe reac-
tions to plant-derived food in Austria.
Thirteen patients reporting strong reactions after con-
sumption of fruits, vegetables or herbs were invited to
skin prick and prick to prick tests. For visualizing
patients’ IgE-reactivity patterns, immunoblots were per-
formed, which allowed the determination of specific IgE
to raw and boiled parsley, raspberry, apricot, and peach.
These immunoblots showed that cooking did not influ-
ence IgE binding to LTPs, while cooking reduced IgE
binding to all Bet v 1-related proteins. We further
observed that LTP-sensitized patients showed variable
IgE reactivity to different LTPs, however, the strongest
reactions were seen to fruits from the Rosaceae family,
especially to peach, suggesting that peach LTP (Pru p 3)
contains the majority of IgE epitopes also for a Central
European population. Analysis of IgE reactivity to single
molecules (including Bet v 1 and Pru p 3) using an
allergen micro-array (ISAC) and single ImmunoCAP
measurements enabled to determine the following sensi-
tization patterns: 1 patient was monosensitized to Bet v
1, 3 were monosensitized to LTP, whereas 8 showed a
co-sensitization to Bet v 1 and LTP and 1 patient was
monosensitized to profilin.
Based on this study, we conclude that analysis of specific
IgE to the LTP Pru p 3 from peach is also sufficient for
diagnosis of reactions to Rosacea fruits even in regions
where frequent co-sensitization to Bet v 1 makes the inter-
pretation of extracts-based skin prick tests difficult. In
addition, also other plant-related panallergens, such as
profilin, should be included in such a differential diagnos-
tic workup scheme.
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